Which has the lower trailing P/E, BMY or TMO?

BMY has the lower trailing P/E: BMY trades at 14.39 and TMO at 31.71. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or TMO?

Over the past five years, TMO grew revenue faster — BMY at a 2.08% CAGR versus TMO at 5.00%.

Does BMY or TMO pay a bigger dividend?

BMY yields 2.88% and TMO yields 0.31% based on trailing dividends and the latest price.

Is BMY or TMO more profitable?

BMY runs the higher net margin — BMY at 18.87% versus TMO at 15.06%.

How have BMY and TMO total returns compared?

Over the past 10 years, BMY delivered 2.19% and TMO delivered 14.01% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Thermo Fisher Scientific Inc. (TMO)

A side-by-side comparison of Bristol-Myers Squibb Company and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$133.37B

$65.31HealthcareAt close: Jul 31, 2026, 4:00 PM ET

TMO

Thermo Fisher Scientific Inc.

$213.42B

$574.30HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — BMY vs TMO

growth of $100 · dividends reinvested · last 30y

BMY +807.5%TMO +1825.5%TMO compounded faster

BMY TMO

BMY vs TMO: by the numbers

•TMO is the larger company ($213.42B vs $133.37B market cap).
•BMY trades at the lower trailing earnings multiple (14.39 vs 31.71 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 15.06% net margin).
•TMO grew revenue faster over the past five years (5.00% vs 2.08% CAGR).
•BMY pays the higher dividend yield (2.88% vs 0.31%).

Metrics side by side

Valuation

Metric	BMY	TMO
P/E ratio	14.39	31.71
Forward P/E	9.88	22.99
P/S ratio	2.72	4.76
P/B ratio	5.99	4.14
PEG ratio	1.53	4.54
EV / EBITDA	9.93	24.22
FCF yield	9.20%	3.14%

Profitability

Metric	BMY	TMO
Gross margin	70.16%	40.37%
Operating margin	28.27%	17.69%
Net margin	18.87%	15.06%
ROE	41.59%	13.24%
ROIC	13.90%	7.58%

Dividends

Metric	BMY	TMO
Dividend yield	2.88%	0.31%
Payout ratio	54.34%	10.13%

Growth (annualized)

Metric	BMY	TMO
Revenue CAGR (5Y)	2.08%	5.00%
EPS CAGR (5Y)	9.38%	1.99%
FCF CAGR (5Y)	-0.69%	-1.83%
Total return CAGR (5Y)	3.38%	1.48%

Frequently asked

Which has the lower trailing P/E, BMY or TMO?: BMY has the lower trailing P/E: BMY trades at 14.39 and TMO at 31.71. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or TMO?: Over the past five years, TMO grew revenue faster — BMY at a 2.08% CAGR versus TMO at 5.00%.
Does BMY or TMO pay a bigger dividend?: BMY yields 2.88% and TMO yields 0.31% based on trailing dividends and the latest price.
Is BMY or TMO more profitable?: BMY runs the higher net margin — BMY at 18.87% versus TMO at 15.06%.
How have BMY and TMO total returns compared?: Over the past 10 years, BMY delivered 2.19% and TMO delivered 14.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Thermo Fisher Scientific P/E ratio Bristol-Myers Squibb dividend yield Thermo Fisher Scientific dividend yield Bristol-Myers Squibb ROE Thermo Fisher Scientific ROE Bristol-Myers Squibb operating margin Thermo Fisher Scientific operating margin Bristol-Myers Squibb revenue growth Thermo Fisher Scientific revenue growth Bristol-Myers Squibb free cash flow Thermo Fisher Scientific free cash flow

Bristol-Myers Squibb & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.